Development and validation of a protein-based signature for the detection of ovarian cancer.
about
Proteomic analyses of serous and endometrioid epithelial ovarian cancers - cases studies - molecular insights of a possible histological etiology of serous ovarian cancer.Relative quantification of serum proteins from pancreatic ductal adenocarcinoma patients by stable isotope dilution liquid chromatography-mass spectrometry.Ovarian cancer: can proteomics give new insights for therapy and diagnosis?The duplicitous origin of ovarian cancer.Serum protein profile at remission can accurately assess therapeutic outcomes and survival for serous ovarian cancer.Correlation between preoperative serum levels of five biomarkers and relationships between these biomarkers and cancer stage in epithelial overian cancer.Macrophage migration inhibitory factor (MIF): a promising biomarker.Tumor markers for early detection of ovarian cancer.Cancer testis antigens: novel biomarkers and targetable proteins for ovarian cancer.Molecular analysis of blood with micro-/nanoscale field-effect-transistor biosensors.Growth factors controlling ovarian functions.Ovarian cancer: biomarker proteomic diagnosis in progress.The dire need to develop a clinically validated screening method for the detection of early-stage ovarian cancer.Pattern rules: biomarker signatures for sensitization as an alternative to animal testing.Mining proteomic data for biomedical research
P2860
Q34669870-C7AFAEE3-D39A-4683-963A-110E3ADAC7F9Q35798915-AD217923-1CE9-4536-B5DC-F3065E8743D8Q36820579-C6587F2C-F6EF-43A5-99EE-6E7FAE23D268Q36919484-15FA0D28-7997-419F-BF40-27B72364F1F2Q37297487-FDABB619-FDFB-464E-9387-B08DD47BEB75Q37376643-8BE5BBCA-71B7-4FEB-AAFC-6A023830F171Q37762450-F2A94A01-CF46-4FBB-98BE-BAF380DBB7BDQ37789033-FDA410BD-50F6-4084-B70E-695725E8E080Q37873930-E17F9CC6-CB76-4C0E-8EE6-854E499031D5Q37884527-30C24277-56CB-41C9-B1D0-D13A2538C496Q37887631-E060A121-A9FF-44A7-9A29-6BEA0EF271EEQ38040333-D97E9238-4A0D-45E0-97B6-106DCDAEE0D7Q43021437-051C55F3-AB67-4955-BEE4-41F0E653BC64Q54338020-1CFBCC8B-7C87-4D5E-848F-C160BB0D8817Q56881273-80386E06-195F-4A04-B7BF-73A9E03900AB
P2860
Development and validation of a protein-based signature for the detection of ovarian cancer.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Development and validation of ...... e detection of ovarian cancer.
@en
Development and validation of ...... e detection of ovarian cancer.
@nl
type
label
Development and validation of ...... e detection of ovarian cancer.
@en
Development and validation of ...... e detection of ovarian cancer.
@nl
prefLabel
Development and validation of ...... e detection of ovarian cancer.
@en
Development and validation of ...... e detection of ovarian cancer.
@nl
P2093
P2860
P1476
Development and validation of ...... e detection of ovarian cancer.
@en
P2093
Ayesha B Alvero
Irene Visintin
Kyongjin Kim
P2860
P356
10.1016/J.CLL.2009.02.001
P577
2009-03-01T00:00:00Z